CJC-1295 DAC

High-Purity CJC-1295 DAC 10mg for Advanced Research

Product Note:This product is intended for laboratory and scientific research purposes only. It is not for human or veterinary use. All bnni]= esearch must be conducted strictly within approved laboratory protocols.

CJC-1295 with DAC (Drug Affinity Complex) is a modified, long-acting synthetic analogue of growth hormone-releasing hormone (GHRH). By incorporating a DAC component, the peptide binds covalently to serum albumin, significantly extending its plasma half-life and duration of action in experimental research settings.

Supplied as a sterile, vacuum-sealed lyophilized (freeze-dried) powder pellet in a clear glass vial, this format ensures optimal stability and high purity for precise laboratory handling. Each vial contains 10mg of high-purity CJC-1295 DAC, verified via analytical HPLC testing.

Key Research Areas:

Investigation of extended half-life GHRH analogs and serum albumin binding dynamics.Studies on pulsatile growth hormone (GH) and insulin-like growth factor 1 (IGF-1) secretion pathways. Research into long-term receptor activation models in experimental endocrinology. Evaluation of metabolic profile alterations in controlled laboratory environments.

Technical Specifications:

Peptide Identity:CJC-1295 with DAC Sequence: Modified GHRH (1-29) peptide conjugated with Drug Affinity ComplexMolecular Formula: C165H269N47O46Molecular Weight: ~3647.2 g/molPurity: ≥ 98% (HPLC verified)Quantity:10 mgFormat: White Lyophilized Powder

Storage and Handling:

Store the lyophilized powder refrigerated (2-8°C) for short-term handling or frozen (-20°C) for long-term storage. Keep protected from light and moisture. Once reconstituted with sterile or bacteriostatic water, maintain proper storage conditions and use within recommended testing windows.